Showing results (381-390 of 415) with videos related to
Sort By:
Pageof 42
Modern Rheumatology|March 11, 2021
Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive studyHideto Takada, Yuko Kaneko, Kazuhisa Nakano, et al.Modern Rheumatology|December 31, 2014
Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort studyEiichi Tanaka, Eisuke Inoue, Daisuke Hoshi, et al.Modern Rheumatology|December 13, 2021
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroidsRei Yamaguchi, Eiichi Tanaka, Ayako Nakajima, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 4, 2020
[Determination of Absolute Purities of Hygroscopic Substances by Quantitative NMR Analysis for the Standardization of Quantitative Reagents in the Japanese Pharmacopoeia (Part 1)]Nahoko Uchiyama, Junko Hosoe, Toru Miura, et al.Modern Rheumatology|November 9, 2021
Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohortTomoaki Higuchi, Eiichi Tanaka, Eisuke Inoue, et al.Modern Rheumatology|January 27, 2015
Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012Eri Sato, Eiichi Tanaka, Moeko Ochiai, et al.Modern Rheumatology|June 9, 2015
Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA databaseDaisuke Hoshi, Eiichi Tanaka, Ataru Igarashi, et al.Modern Rheumatology|August 3, 2022
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohortNaoki Sugimoto, Eiichi Tanaka, Eisuke Inoue, et al.Modern Rheumatology|December 24, 2014
Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practiceEri Sato, Eiichi Tanaka, Ayako Nakajima, et al.Modern Rheumatology|December 18, 2020
Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort studyRintaro Saito, Masao Tanaka, Hiromu Ito, et al.Pageof 42